🇺🇸 FDA
Patent

US 7351791

Intermediate for preparing glycopeptide derivatives

granted A61KA61K38/00A61P

Quick answer

US patent 7351791 (Intermediate for preparing glycopeptide derivatives) held by Theravance, Inc. expires Mon Mar 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Apr 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K38/00, A61P, A61P31/04